CD8A and neoplasm: In agreement with previous reports, systemic DNCB induced a mild inhibitory effect on tumor growth (Figure 6B), associated with an increase in CD4+ and CD8+ T-cell levels in the tumor infiltrates (Figure 6C), without significant changes in these population in the spleen (Figure 6D).